0001651944-24-000028.txt : 20240416 0001651944-24-000028.hdr.sgml : 20240416 20240416160848 ACCESSION NUMBER: 0001651944-24-000028 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20240415 ITEM INFORMATION: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing FILED AS OF DATE: 20240416 DATE AS OF CHANGE: 20240416 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DermTech, Inc. CENTRAL INDEX KEY: 0001651944 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 842870849 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38118 FILM NUMBER: 24847889 BUSINESS ADDRESS: STREET 1: 12340 EL CAMINO REAL CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 858-450-4222 MAIL ADDRESS: STREET 1: 12340 EL CAMINO REAL CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: Constellation Alpha Capital Corp. DATE OF NAME CHANGE: 20150827 8-K 1 dmtk-20240415.htm 8-K dmtk-20240415
NasdaqFALSE000165194400016519442024-04-152024-04-15

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 15, 2024
DERMTECH, INC.
(Exact name of registrant as specified in its charter)
Delaware001-3811884-2870849
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
12340 El Camino Real
San Diego, CA 92130
(Address of Principal Executive Offices and Zip Code)
Registrant’s telephone number, including area code (858) 450-4222
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
oWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
oSoliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
oPre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
oPre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock,
par value $0.0001 per share
DMTK
The Nasdaq Capital Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company o
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o








Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

On April 15, 2024, DermTech, Inc. (the “Company”) received written notice (the “Notice”) from the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market (“Nasdaq”) notifying the Company that, for the preceding 30 consecutive business days, the bid price of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), closed below the minimum $1.00 per share requirement for continued inclusion under Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”).

In accordance with Nasdaq rules, the Company has been provided a 180-calendar day compliance period, or until October 14, 2024 (the “Compliance Date”), to regain compliance with the Minimum Bid Price Requirement. To regain compliance with the Minimum Bid Price Requirement, the closing bid price of the Common Stock must meet or exceed $1.00 per share for a minimum of ten consecutive business days during the 180-calendar day compliance period. Pursuant to Nasdaq Listing Rule 5810(c)(3)(A)(iii), if the price of the Common Stock is less than $0.10 during a compliance period, the Staff will issue a delisting determination for the Common Stock.

If the Company is not in compliance with the Minimum Bid Price Requirement by the Compliance Date, the Company may qualify for a second 180-calendar day compliance period. To qualify for this additional compliance period, the Company will be required to meet the continued listed requirement for market value of publicly held shares and all other initial listing standards for the Nasdaq Capital Market, with the exception of the Minimum Bid Price Requirement, and must notify Nasdaq in writing of its intention to cure the deficiency during the second compliance period.

If the Company does not regain compliance with the Minimum Bid Price Requirement by the Compliance Date and is not eligible for an additional compliance period at that time, the Staff will provide written notification to the Company that its Common Stock will be subject to delisting. At that time, the Company may appeal the delisting determination to a Nasdaq Hearing Panel. There can be no assurance that the Company will regain compliance or otherwise maintain compliance with any of the other listing requirements.

The Notice has no immediate effect on the Company’s continued listing on the Nasdaq Capital Market, subject to the Company’s compliance with the other continued listing requirements. The Notice also does not affect the Company’s business operations or its Securities and Exchange Commission reporting requirements.

The Company intends to actively monitor the closing bid price of its Common Stock and may, if appropriate, consider implementing available options to regain compliance with the Minimum Bid Price Requirement.


SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
DERMTECH, INC.
Date: April 16, 2024By:/s/ Kevin Sun
Name:Kevin Sun
Title:Chief Financial Officer

 EX-101.SCH 2 dmtk-20240415.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover Page link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 3 dmtk-20240415_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Entity Central Index Key Entity Central Index Key Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Trading Symbol Trading Symbol Entity File Number Entity File Number Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Soliciting Material Soliciting Material Entity Address, City or Town Entity Address, City or Town Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Local Phone Number Local Phone Number Entity Address, Postal Zip Code Entity Address, Postal Zip Code Written Communications Written Communications City Area Code City Area Code Cover [Abstract] Title of 12(b) Security Title of 12(b) Security Document Type Document Type Amendment Flag Amendment Flag Security Exchange Name Security Exchange Name Entity Registrant Name Entity Registrant Name Entity Emerging Growth Company Entity Emerging Growth Company Entity Address, State or Province Entity Address, State or Province Document Period End Date Document Period End Date Pre-commencement Tender Offer Pre-commencement Tender Offer EX-101.PRE 4 dmtk-20240415_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 6 R1.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Cover Page
Apr. 15, 2024
Cover [Abstract]  
Document Type 8-K
Document Period End Date Apr. 15, 2024
Entity Registrant Name DERMTECH, INC.
Entity Incorporation, State or Country Code DE
Entity File Number 001-38118
Entity Tax Identification Number 84-2870849
Entity Address, Address Line One 12340 El Camino Real
Entity Address, City or Town San Diego
Entity Address, State or Province CA
Entity Address, Postal Zip Code 92130
City Area Code 858
Local Phone Number 450-4222
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock,par value $0.0001 per share
Trading Symbol DMTK
Entity Emerging Growth Company false
Amendment Flag false
Entity Central Index Key 0001651944
Security Exchange Name NASDAQ
EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.u1 html 1 22 1 false 0 0 false 0 false false R1.htm 0000001 - Document - Cover Page Sheet http://dermtech.com/role/CoverPage Cover Page Cover 1 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: dei:SecurityExchangeName - dmtk-20240415.htm 4 dmtk-20240415.htm dmtk-20240415.xsd dmtk-20240415_lab.xml dmtk-20240415_pre.xml http://xbrl.sec.gov/dei/2022 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "dmtk-20240415.htm": { "nsprefix": "dmtk", "nsuri": "http://dermtech.com/20240415", "dts": { "inline": { "local": [ "dmtk-20240415.htm" ] }, "schema": { "local": [ "dmtk-20240415.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] }, "labelLink": { "local": [ "dmtk-20240415_lab.xml" ] }, "presentationLink": { "local": [ "dmtk-20240415_pre.xml" ] } }, "keyStandard": 22, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 3, "http://xbrl.sec.gov/dei/2022": 3 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 23, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2022": 23 }, "report": { "R1": { "role": "http://dermtech.com/role/CoverPage", "longName": "0000001 - Document - Cover Page", "shortName": "Cover Page", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "dmtk-20240415.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "dmtk-20240415.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "AmendmentFlag", "presentation": [ "http://dermtech.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "CityAreaCode", "presentation": [ "http://dermtech.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "DocumentPeriodEndDate", "presentation": [ "http://dermtech.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "DocumentType", "presentation": [ "http://dermtech.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityAddressAddressLine1", "presentation": [ "http://dermtech.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityAddressCityOrTown", "presentation": [ "http://dermtech.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://dermtech.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://dermtech.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityCentralIndexKey", "presentation": [ "http://dermtech.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://dermtech.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityFileNumber", "presentation": [ "http://dermtech.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://dermtech.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityRegistrantName", "presentation": [ "http://dermtech.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://dermtech.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "LocalPhoneNumber", "presentation": [ "http://dermtech.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://dermtech.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Issuer Tender Offer", "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "PreCommencementTenderOffer", "presentation": [ "http://dermtech.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Tender Offer", "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "Security12bTitle", "presentation": [ "http://dermtech.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "SecurityExchangeName", "presentation": [ "http://dermtech.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "SolicitingMaterial", "presentation": [ "http://dermtech.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Soliciting Material", "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "TradingSymbol", "presentation": [ "http://dermtech.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "WrittenCommunications", "presentation": [ "http://dermtech.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Written Communications", "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 15 0001651944-24-000028-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001651944-24-000028-xbrl.zip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end XML 17 dmtk-20240415_htm.xml IDEA: XBRL DOCUMENT 0001651944 2024-04-15 2024-04-15 NASDAQ false 0001651944 8-K 2024-04-15 DERMTECH, INC. DE 001-38118 84-2870849 12340 El Camino Real San Diego CA 92130 858 450-4222 false false false false Common Stock,par value $0.0001 per share DMTK NASDAQ false